Agios Pharmaceuticals | AGIO - Equity Capital And Reserves

Agios Pharmaceuticals reported $1.1B in Equity Capital and Reserves for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Equity Capital And Reserves Change
Agios Pharmaceuticals AGIO:US USD 1.1B 50.64M
Alnylam Pharmaceuticals ALNY:US USD -158223000 90.58M
Amgen AMGN:US USD 3.66B 8M
Arrowhead Research ARWR:US USD 377.04M 21.48M
Astellas Pharma 4503:JP JPY 1.57T 79.09B
AstraZeneca AZN:LN USD 37.04B 1.9B
Bayer BAYN:GR EUR 38.77B 2.5B
Biogen BIIB:US USD 13.4B 622.4M
Biomarin Pharmaceutical BMRN:US USD 4.6B 34.64M
Bluebird Bio BLUE:US USD 158.86M 21.26M
Daiichi Sankyo 4568:JP JPY 1.41T 52.83B
Exelixis EXEL:US USD 2.49B 2.97M
Gilead Sciences GILD:US USD 21.21B 128M
GlaxoSmithKline GSK:LN GBP 10.6B 1.45B
Immunogen IMGN:US USD 155.83M 22.18M
IONIS PHARMACEUT IONS:US USD 572.89M 21.47M
JAZZ PHA JAZZ:US USD 3.09B 340.54M
Mirati Therapeutics MRTX:US USD 996.52M 132.54M
Moderna Inc MRNA:US USD 19.12B 1.13B
Nektar Therapeutics NKTR:US USD 366.64M 45.58M
Novartis NOVN:VX USD 59.34B 1.48B
Novartis NVS:US USD 59.34B 1.48B
Puma Biotechnology PBYI:US USD 21.61M 547K
Regeneron Pharmaceuticals REGN:US USD 22.66B 1.23B
Roche Holding ROG:VX 27.99B 2.8B
Sarepta Therapeutics SRPT:US USD 384.95M 45.89M
Seattle Genetics SGEN:US USD 2.8B 17.99M
Vertex Pharmaceuticals VRTX:US USD 13.91B 883.1M
YTE INCY:US USD 4.37B 143.47M